Cluster of differentiation 33 single nucleotide polymorphism rs12459419 is a predictive factor in patients with nucleophosmin1-mutated acute myeloid leukemia receiving gemtuzumab ozogamicin - Teich, Katrin; Krzykalla, Julia; Kapp-Schwoerer, Silke; Gaidzik, Verena Ingeborg; Schlenk, Richard Friedrich; Paschka, Peter; Weber, Daniela; Fiedler, Walter; Kühn, Michael W.M.; Schroeder, Thomas; Mayer, Karin; Lübbert, Michael; et al. (Haematologica, 2021)
Gesehen am 27.04.2022